Neurotoxicity

Clinical Update

Exploring the Potential Neurotoxicity of Antipsychotics in Younger Populations

Topics: Antipsychotics | Autism | Autism Spectrum Disorder | Neurotoxicity

At Carlat, we bang the drum of caution about antipsychotic use in children and adolescents. In this article, we pair rising concerns about antipsychotic neurotoxicity with the lack of efficacy evidence for off-label usage. Labeled use It is important to treat psychosis. A recent review by Goff and colleagues shows better outcomes for people who rece

Read More
Expert Q&A

Getting Uncomfortable with Esketamine

Topics: Antidepressant Augmentation | Antidepressants | Brain Devices | Depression | Depressive Disorder | ECT | Esketamine | Ketamine | Neurotoxicity | Novel Medications | rTMS | Suicidality | TMS | Transcranial Magnetic Stimulation | Treatment-Resistant Depression

Esketamine (Spravato) was approved for treatment-resistant depression in 2019. In this interview, Dr. Williams (who has no relationship with Janssen Pharmaceuticals, Inc) addresses some lingering doubts that have been raised about the medicine. TCPR: Where does esketamine fit in the list of interventional therapies for depression, like repetitive trans

Read More